Radiation planning to spare the opposite neck in head cancer
Part of Cancer clinical trials.
This trial tests a safer radiation plan that may reduce dose to the opposite (other) side of the neck while still treating the cancer spread risk. It uses special mapping to guide treatment and looks at patients whose cancer is already in an involved lymph node on one side.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You agree to take part in the study and sign consent before any study tests
- You’re age 18 or older, and your daily function is fairly good (WHO performance status 0–1)
- You have invasive head and neck cancer of the mouth, throat, voice box, or lower throat (not other head/neck sites)
- Your scan shows no cancer spread to the distant body, and specific lymph-node results in the opposite neck side
- Your cancer treatment plan must be radical radiotherapy (with or without chemotherapy) decided by a tumor team
- Your CT/PET scan of the neck is of diagnostic quality and meets the study’s measurements of node size and scan activity
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to guide radiation treatment for a type of throat cancer that is on one side only. The goal is to see if using a special scan (SPECT-CT) to map lymph drainage can help doctors decide how to treat the neck more precisely and reduce side effects.
This trial tests whether giving a slightly different schedule of radiation (more frequent, smaller doses) can improve treatment for people with large head and neck cancers. It is for patients who are getting radiation as their main treatment, sometimes with chemotherapy as well.
This trial compares two treatments for certain head and neck cancers: radiation therapy alone given more often (hyperfractionated) versus radiation combined with chemotherapy. The goal is to see if one approach is better at controlling the cancer while limiting side effects.
This trial looks at whether giving less (de-escalated) radiation after surgery is as effective and safer for people with locally advanced head and neck squamous cell carcinoma who had a strong response to treatment before surgery. If you had no remaining cancer or only very small amounts of cancer left in the surgical specimen, this approach may help reduce side effects while keeping control of the disease.
This study tests whether giving less radiation after surgery is as effective as standard radiation for people with a specific type of neck cancer that started somewhere unknown. It aims to reduce side effects while keeping the cancer from coming back.
This study tests whether using a special scan (SPECT-CT) can guide radiation treatment to only the safer/needed side of the neck in people with a one-sided oropharyngeal cancer. It aims to keep cancer control while potentially reducing side effects from unnecessary radiation.
Hear when a new Squamous Cell Carcinoma of Head and Neck trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.